Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.46 |
| ▸ | MEN1 | O00255 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CDK1 | P06493 | 2/20 | 0.40 |
| ▸ | CDK2 | P24941 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13419113 | 0.92 | CDK1 (0.42) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL20024341 | 0.91 | MAPT (0.47) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL20024297 | 0.89 | MAPT (0.47) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL10184655 | 0.87 | KMT2A (0.51) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL10184657 | 0.87 | MAPT (0.37) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL15077053 | 0.86 | KMT2A (0.53) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL10233085 | 0.86 | KMT2A (0.56) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL10184654 | 0.85 | KMT2A (0.51) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL622500 | 0.83 | MAPT (0.50) | MAPTKMT2AMEN1ALDH1A1PKM | |
| SCHEMBL622499 | 0.83 | MAPT (0.50) | MAPTKMT2AMEN1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293436-B2 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8293436-B2 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8124304-B2 | Dye-containing curable composition, color filter and method for producing the same | FUJIFILM CORPORATION (JP) | 2012-02-28 | — | — | US | disclosed |
| US-8124304-B2 | Dye-containing curable composition, color filter and method for producing the same | FUJIFILM CORPORATION (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20100104976-A1 | OXIME DERIVATIVE, PHOTOPOLYMERIZABLE COMPOSITION, COLOR FILTER, AND PROCESS FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20100104976-A1 | OXIME DERIVATIVE, PHOTOPOLYMERIZABLE COMPOSITION, COLOR FILTER, AND PROCESS FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| US-7674503-B2 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2010-03-09 | — | — | US | disclosed |
| US-7674503-B2 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2010-03-09 | — | — | US | disclosed |
| US-7572559-B2 | Colorant-containing curable composition, color filter and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2009-08-11 | — | — | US | disclosed |
| US-20090049624-A1 | DYE-CONTAINING CURABLE COMPOSITION, COLOR FILTER AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090049624-A1 | DYE-CONTAINING CURABLE COMPOSITION, COLOR FILTER AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20070203255-A1 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070203255-A1 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-7193068-B2 | Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-7193068-B2 | Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-20070049650-A1 | Colorant-containing curable composition, color filter and manufacturing method thereof | FUJI PHOTO FILM CO., LTD. | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104976-A1 | OXIME DERIVATIVE, PHOTOPOLYMERIZABLE COMPOSITION, COLOR FILTER, AND PROCESS FOR PRODUCING THE SAME | PPOX, CYBA, HBB | MAPT 2701/4885KMT2A 754/4885MEN1 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.